Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2010 | 01-2010 | 10-2009 | 07-2009 | 04-2009 | |
| Sales | 23,788 | 23,186 | 25,165 | 24,531 | 23,061 |
| Cost of Goods | 13,257 | 12,301 | 11,836 | 13,905 | 13,355 |
| Gross Profit | 10,531 | 10,885 | 13,329 | 10,626 | 9,706 |
| Operating Expenses | 15,054 | 21,227 | 16,028 | 17,071 | 14,380 |
| Operating Income | -4,266 | -10,041 | -1,863 | -5,540 | -4,319 |
| Other Income | -133 | -169 | -30 | 88 | 93 |
| Pre-tax Income | -4,399 | -10,210 | -1,893 | -5,452 | -4,226 |
| Income Tax | 177 | 118 | -79 | -173 | 16 |
| Net Income Continuous | -4,576 | -10,328 | -1,814 | -5,279 | -4,242 |
| Net Income | $-4,576 | $-10,328 | $-1,814 | $-5,279 | $-4,242 |
| EPS Basic Total Ops | -0.12 | -0.27 | -0.05 | -0.15 | -0.11 |
| EPS Basic Continuous Ops | -0.12 | -0.27 | -0.05 | -0.14 | -0.11 |
| EPS Diluted Total Ops | -0.12 | -0.27 | -0.05 | -0.15 | -0.11 |
| EPS Diluted Continuous Ops | -0.12 | -0.27 | -0.05 | -0.14 | -0.11 |
| EBITDA(a) | $-3,229 | $-8,797 | $-920 | $-4,429 | $-3,490 |